TCL Archive Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials September 26, 2014
TCL Archive Senate Bill Would Authorize $1 Billion for NCI; House Version Senate Bill Would Authorize $1 Billion for NCI; House Version Approved April 8, 1977
TCL Archive Research community needs to be prepared for budget “flattening,” NCI director says. March 25, 2005
TCL Archive Slow Accruing Trials Should Be Removed From High Priority Program, Broder Says October 2, 1992
